AstraZeneca COVID-19 vaccine study paused after one illness

AstraZeneca COVID-19 vaccine study paused after one illness

AstraZeneca COVID-19 vaccine study paused after one illness

Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot.

In a statement issued Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data.”

AstraZeneca didn’t reveal any information about the possible side effect except to call it “a potentially unexplained illness.” The health news site STAT first reported the pause in testing, saying the possible side effect occurred in the United Kingdom.

An AstraZeneca spokesperson confirmed the pause in vaccinations covers studies in the U.S. and other countries. Late last month, AstraZeneca began recruiting 30,000 people in the U.S. for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain, and in smaller studies in Brazil and South Africa.

Two other vaccines are in huge, final-stage tests in the United States, one made by Moderna Inc. and the other by Pfizer and Germany’s BioNTech. Those two vaccines work differently than AstraZeneca’s, and the studies already have recruited about two-thirds of the needed volunteers.

Temporary holds of large medical studies aren’t unusual, and investigating any serious or unexpected reaction is a mandatory part of safety testing. AstraZeneca pointed out that it’s possible the problem could be a coincidence; illnesses of all sorts could arise in studies of thousands of people.

“We are working to expedite the review of the single event to minimize any potential impact on the trial timeline,” the company statement said.

It’s likely the unexplained illness was serious enough to require hospitalization and not a mild side effect such as fever or muscle pain, said Deborah Fuller, a University of Washington researcher who is working on a different COVID-19 vaccine that has not yet started human testing.

“This is not something to be alarmed about,” Fuller said. Instead, it’s reassuring that the company is pausing the study to figure out what’s happening and carefully monitoring the health of study participants.

Dr. Ashish Jha of Brown University said via Twitter that the significance of the interruption was unclear but that he was “still optimistic” that an effective vaccine will be found in the coming months.

“But optimism isn’t evidence,” he wrote. “Let’s let science drive this process.”

Angela Rasmussen, a virologist at Columbia University in New York, tweeted that the illness may be unrelated to the vaccine, “but the important part is that this is why we do trials before rolling out a vaccine to the general public.”

During the third and final stage of testing, researchers look for any signs of possible side effects that may have gone undetected in earlier patient research. Because of their large size, the studies are considered the most important study phase for picking up less common side effects and establishing safety.

The trials also assess effectiveness by tracking who gets sick and who doesn’t between patients getting the vaccine and those receiving a dummy shot.

The development came the same day that AstraZeneca and eight other drugmakers issued an unusual pledge, vowing to uphold the highest ethical and scientific standards in developing their vaccines.

The announcement follows worries that President Donald Trump will pressure the U.S. Food and Drug Administration to approve a vaccine before it’s proven to be safe and effective.

The U.S. has invested billions of dollars in efforts to quickly develop multiple vaccines against COVID-19. But public fears that a vaccine is unsafe or ineffective could be disastrous, derailing the effort to vaccinate millions of Americans.

Representatives for the FDA did not immediately respond to requests for comment Tuesday evening.

AstraZeneca’s U.S.-traded shares fell more than 6% in after-hours trading following reports of the trial being paused.

___

Associated Press writers Matthew Perrone and Carla K. Johnson contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Lauran Neergaard, The Associated Press

vaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

The Salvation Army's 2020 Christmas Kettle Campaign includes a new $5 tap feature for pandemic-friendly donations. (Devon Bidal/News Staff)
Salvation Army officers safe, touchless options for Kettle donation this year

The Salvation Army in Red Deer needs help. Kettle donations are needed… Continue reading

The Central Alberta Humane Society is looking for volunteers. (Photo contributed)
Central Alberta Humane Society looking for volunteers

The Central Alberta Humane Society is in need of volunteers Dec. 11… Continue reading

RCMP. (Phil McLachlan - Black Press Media)
Drumheller RCMP arrest local drug dealer

A joint forces investigation involving Drumheller RCMP and ALERT has led to… Continue reading

Red Deer Advocate file photo
Ex-mountie found not guilty of sexual assault in Red Deer court

An ex-mountie who was accused of sexually assaulting a fellow RCMP officer… Continue reading

The City of Red Deer has opened its 77 outdoor rinks for skating and hockey. (Photo courtesy of The City of Red Deer)
Red Deer city outdoor rinks ready to go

It’s time to dust of the skates for outdoor rinks. The City… Continue reading

Dan Cochrane, senior pastor at CrossRoads Church. Contributed photo
CrossRoads Church closes its doors for two weeks after staff member tests positive for COVID-19

CrossRoads Church made the decision to cancel in-house services for two weeks… Continue reading

Blank Unemployment Benefits form
Red Deer jobless rate down slightly in November

Red Deer’s unemployment rate dropped by half a per cent in November.… Continue reading

Apartments are seen lit up in downtown Vancouver as people are encouraged to stay home during the global COVID-19 pandemic on Thursday, Dec. 3, 2020. British Columbia's deputy provincial health officer says provincewide data show the most important area B.C. must tackle in its response to the COVID-19 pandemic is health inequity. THE CANADIAN PRESS/Marissa Tiel
Age, income among top factors affecting health during pandemic in B.C., survey shows

VANCOUVER — British Columbia’s deputy provincial health officer says a survey on… Continue reading

A woman pays her respects to victims of a mass shooting at a roadblock in Portapique, N.S. on Wednesday, April 22, 2020. THE CANADIAN PRESS/Andrew Vaughan
Three charged, including spouse, with supplying ammunition to N.S. mass shooter

HALIFAX — Three people, including the killer’s former spouse, have been charged… Continue reading

Downtown Iqaluit, Nunavut, is shown after 2 p.m. sunset on Tuesday, Nov. 24, 2020. Nunavut will look to get the Moderna vaccine once it is available in Canada. Chief public health officer Dr. Michael Patterson says Moderna is preferred because the cold storage and shipping of the Pfizer vaccine is too difficult in the northern territory. THE CANADIAN PRESS/Emma Tranter
Moderna COVID vaccine best for Nunavut because of storage, shipping: top doctor

IQALUIT, Nunavut — Nunavut is looking to get the Moderna COVID-19 vaccine… Continue reading

Farmers raise slogans during a protest on a highway at the Delhi-Haryana state border, India, Thursday, Dec. 3, 2020. Prime Minister Justin Trudeau rejected the diplomatic scolding Canada’s envoy to India received on Friday for his recent comments in support of protesting Indian farmers. Tens of thousands of farmers have descended upon the borders of New Delhi to protest new farming laws that they say will open them to corporate exploitation. THE CANADIAN PRESS/AP-Manish Swarup
Trudeau affirms farmers’ right to demonstrate after India criticizes his remarks

OTTAWA — Prime Minister Justin Trudeau rejected the diplomatic scolding Canada’s envoy… Continue reading

Nurse Kath Olmstead prepares a shot as the world’s biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y. U.S. biotech firm Moderna says its vaccine is showing signs of producing lasting immunity to COVID-19, and that it will have as many as many as 125 million doses available by the end of March. THE CANADIAN PRESS/AP-Hans Pennink
Canada’s COVID-19 case count passes 400,000 mark

OTTAWA — Canada has now recorded more than 400,000 cases of COVID-19… Continue reading

Longtime central Alberta politician Judy Gordon has passed away. Photo courtesy of the City of Lacombe
Former Lacombe Mayor Judy Gordon passes away

Gordon also served as MLA for Lacombe-Stettler before retiring from politics in 2010

Alberta Health Minister Tyler Shandro (left) and Alberta Chief Medical Officer of Health Dr. Deena Hinshaw pose for a photo after they received a flu shot earlier this year. Hinshaw has been encouraging Albertans to get a flu shot this season. As of Nov. 28, Central zone has already administered 122,314 doses of the flu vaccine, compared to 126,288 last season. (Photo by Chris Schwarz/Government of Alberta)
Alberta’s flu vaccine distribution already closing in on last year’s totals

Central zone has administered 122,000 doses of influenza vaccine

Most Read